Crystal structure of the catalytic domain of human JARID1B in complex with 3D fragment 2-piperidin-4-yloxy-5-(TRIFLUOROMETHYL)PYRIDINE (N10072A) (ligand modelled based on pandda event MAP)

Structure

x-ray diffraction · 1 distinct chain · 37% helix, 20% strand (DSSP).

Ligands and binding sites

• 80Q · 2-piperidin-4-yloxy-5-(trifluoromethyl)pyridine · ligand · chains A
• ZN · Zinc ion · metal · 2 copies · chains A
• MN · Manganese (II) ion · metal · chains A
• CL · Chloride ion · ion · chains A
• EDO · 1,2-ethanediol · additive · 10 copies · chains A
• DMS · Dimethyl sulfoxide · additive · 4 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

Compared structures

• 5FZA · Crystal structure of the catalytic domain of human JARID1B in complex with 3D fragment… · the same entry in another collection · chain A against A, TM-score 1.00
• Q9UGL1 · AlphaFold monomer V2.0 prediction for lysine-specific demethylase 5B (Q9UGL1) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

• Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
• Every structure of UniProt Q9UGL1
• Elsewhere: RCSB PDB 5FZA · PDBe 5FZA · UniProt Q9UGL1